Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
34
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | 28 | $53.63M | $28.26M | 2026-10-02 |
| RA Capital Healthcare Fund LP | 10% Owner | 2 | $0 | $0 | 2026-08-24 |
| Shah Rajeev M. | Director, 10% Owner | 26 | $0 | $26.55M | 2026-07-16 |
| ZACCARDELLI DAVID | Director | 1 | $0 | $0 | 2026-07-07 |
| Joustra Wouter | Director | 2 | $0 | $0 | 2026-06-11 |
| Levin Andrew David | Director | 2 | $0 | $0 | 2026-06-11 |
| Detheux Michel | Director | 2 | $0 | $0 | 2026-06-11 |
| Namouni Fouad | Director | 4 | $0 | $0 | 2026-06-11 |
| Cumbo Alexander | Director | 2 | $0 | $0 | 2026-06-11 |
| Beckman Daniella | Director | 6 | $0 | $0 | 2026-06-11 |
| Kalir Erez | Director | 3 | $0 | $0 | 2026-06-11 |
| Kolchinsky Peter | Director, 10% Owner | 15 | $0 | $24.89M | 2026-06-11 |
| Zuraw Qing Che | Chief Development Officer | 4 | $0 | $0 | 2025-12-05 |
| Kress Jean-Paul | CEO and Chairman | 3 | $0 | $0 | 2025-12-05 |
| Mahatme Sandesh | CFO | 3 | $0 | $0 | 2025-12-05 |
| Reprogrammed Interchange LLC | 10% Owner | 28 | $0 | $15.80M | 2025-10-21 |
| RA Capital Nexus Fund, L.P. | Director | 5 | $0 | $3.43M | 2025-10-21 |
| Hoffman Reid | 10% Owner | 16 | $0 | $11.88M | 2025-09-16 |
| Reed Sarah Burgess | Director | 1 | $0 | $0 | 2025-09-08 |
| Resnick Joshua | Director | 5 | $0 | $0 | 2025-05-22 |
| Lundberg Sven Ante | Director | 5 | $0 | $0 | 2025-05-22 |
| Lubner David Charles | Director | 5 | $0 | $0 | 2025-05-22 |
| Patterson Matthew R | Director | 5 | $0 | $0 | 2025-05-22 |
| Chakraborty Tirtha | Chief Scientific Officer | 48 | $0 | $0 | 2025-05-06 |
| ANG ROBERT | President and CEO | 43 | $0 | $0 | 2025-05-06 |
| Choi Han Wook | Chief Financial Officer | 4 | $0 | $0 | 2025-05-01 |
| Attar Eyal C. | Chief Medical Officer | 29 | $0 | $39.9K | 2025-02-13 |
| Quinlan Amy | Vice President of Finance | 5 | $0 | $0 | 2024-11-06 |
| Jorgensen Nathan D. | Chief Financial Officer | 18 | $0 | $0 | 2024-05-06 |
| PARMAR KUSH | Director, 10% Owner | 12 | $10.00M | $5.06M | 2022-06-14 |
| Slapak Christopher | Chief Medical Officer | 1 | $0 | $0 | 2022-02-01 |
| Schwab Andrew J. | 10% Owner | 2 | $0 | $5.06M | 2021-11-16 |
| 5AM Opportunities I (GP), LLC | 10% Owner | 8 | $10.00M | $0 | 2021-02-09 |
| Alexandria Venture Investments, LLC | 10% Owner | 2 | $0 | $0 | 2021-02-09 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | M Exercise deriv | 2026-10-02 | 2026-10-05 | 500 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | M Exercise | 2026-10-02 | 2026-10-05 | 500 | $12.80 | $6.4K | 500 | SEC↗ |
| RA Capital Healthcare Fund LP | 10% Owner | M Exercise deriv | 2026-08-24 | 2026-08-26 | 1,500 | — | $0 | 0 | SEC↗ |
| RA Capital Healthcare Fund LP | 10% Owner | M Exercise | 2026-08-24 | 2026-08-26 | 1,500 | $3.74 | $5.6K | 1,500 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | M Exercise deriv | 2026-08-24 | 2026-08-26 | 1,500 | — | $0 | 0 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | M Exercise | 2026-08-24 | 2026-08-26 | 1,500 | $3.74 | $5.6K | 1,500 | SEC↗ |
| Shah Rajeev M. | 10% Owner | X Exercise deriv | 2026-07-16 | 2026-07-21 | 2,100,000 | $5.00 | $10.50M | 7,900,000 | SEC↗ |
| Shah Rajeev M. | 10% Owner | S Sale | 2026-07-16 | 2026-07-21 | 213 | $19.75 | $4.2K | 4,501,882 | SEC↗ |
| Shah Rajeev M. | 10% Owner | X Exercise | 2026-07-16 | 2026-07-21 | 2,100,000 | — | $0 | 4,502,095 | SEC↗ |
| ZACCARDELLI DAVID | Director | A Award deriv | 2026-07-07 | 2026-07-09 | 42,658 | — | $0 | 42,658 | SEC↗ |
| Levin Andrew David | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 57,162 | — | $0 | 57,162 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 53,283 | — | $0 | 53,283 | SEC↗ |
| Cumbo Alexander | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 56,345 | — | $0 | 56,345 | SEC↗ |
| Kalir Erez | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 57,162 | — | $0 | 57,162 | SEC↗ |
| Joustra Wouter | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 57,162 | — | $0 | 57,162 | SEC↗ |
| Namouni Fouad | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 56,549 | — | $0 | 56,549 | SEC↗ |
| Detheux Michel | Director | A Award deriv | 2026-06-11 | 2026-06-12 | 57,162 | — | $0 | 57,162 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2026-06-11 | 2026-06-12 | 57,162 | — | $0 | 57,162 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2026-04-22 | 2026-04-24 | 165,150 | $15.77 | $2.60M | 2,402,095 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2026-04-20 | 2026-04-21 | 171,963 | $15.77 | $2.71M | 2,567,245 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2026-04-17 | 2026-04-21 | 458,411 | $16.28 | $7.46M | 2,739,208 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2026-04-15 | 2026-04-15 | 53,644 | $16.01 | $858.8K | 3,197,619 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2026-04-14 | 2026-04-15 | 153,735 | $15.97 | $2.46M | 3,251,263 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2026-04-13 | 2026-04-15 | 530,610 | $16.15 | $8.57M | 3,404,998 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2026-04-10 | 2026-04-10 | 828 | $15.75 | $13.0K | 3,935,608 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2026-04-09 | 2026-04-10 | 135,201 | $16.59 | $2.24M | 3,936,436 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2026-04-08 | 2026-04-10 | 353,242 | $16.32 | $5.76M | 4,202,499 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2026-04-08 | 2026-04-10 | 130,862 | $16.91 | $2.21M | 4,071,637 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2026-04-06 | 2026-04-06 | 537,754 | $16.51 | $8.88M | 4,607,244 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2026-04-06 | 2026-04-06 | 6,775 | $18.50 | $125.3K | 4,555,741 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2026-04-06 | 2026-04-06 | 44,728 | $17.31 | $774.2K | 4,562,516 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2026-04-02 | 2026-04-06 | 258,475 | $18.23 | $4.71M | 5,146,523 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2026-04-02 | 2026-04-06 | 1,525 | $19.06 | $29.1K | 5,144,998 | SEC↗ |
| Levin Andrew David | Director | A Award deriv | 2025-12-18 | 2025-12-19 | 3,000 | — | $0 | 3,000 | SEC↗ |
| Joustra Wouter | Director | A Award deriv | 2025-12-18 | 2025-12-19 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | A Award deriv | 2025-12-18 | 2025-12-19 | 3,000 | — | $0 | 3,000 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | A Award | 2025-12-18 | 2025-12-19 | 4,625,346 | $10.81 | $50.00M | 5,404,998 | SEC↗ |
| Kress Jean-Paul | CEO and Chairman | D To issuer deriv | 2025-12-05 | 2025-12-09 | 4,164,831 | — | $0 | 0 | SEC↗ |
| Kress Jean-Paul | CEO and Chairman | A Award deriv | 2025-12-05 | 2025-12-09 | 4,164,831 | — | $0 | 4,164,831 | SEC↗ |
| Zuraw Qing Che | Chief Development Officer | A Award deriv | 2025-12-05 | 2025-12-09 | 218,652 | — | $0 | 218,652 | SEC↗ |
| Zuraw Qing Che | Chief Development Officer | D To issuer deriv | 2025-12-05 | 2025-12-09 | 218,652 | — | $0 | 0 | SEC↗ |
| Mahatme Sandesh | CFO | A Award deriv | 2025-12-05 | 2025-12-09 | 1,388,274 | — | $0 | 1,388,274 | SEC↗ |
| Mahatme Sandesh | CFO | D To issuer | 2025-12-05 | 2025-12-09 | 694,137 | — | $0 | 0 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-10-30 | 2025-10-30 | 24,579 | $25.12 | $617.4K | 779,652 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-10-29 | 2025-10-30 | 251,518 | $25.22 | $6.34M | 804,231 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-10-28 | 2025-10-30 | 87,828 | $27.10 | $2.38M | 1,092,232 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | S Sale | 2025-10-28 | 2025-10-30 | 36,483 | $28.18 | $1.03M | 1,055,749 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-10-27 | 2025-10-27 | 90,941 | $28.12 | $2.56M | 1,180,060 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-10-24 | 2025-10-27 | 53,345 | $28.01 | $1.49M | 1,271,001 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | S Sale | 2025-10-23 | 2025-10-27 | 76,880 | $28.01 | $2.15M | 1,324,346 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-21 | 2025-10-21 | 200 | $30.08 | $6.0K | 1,166,909 | SEC↗ |
| RA Capital Nexus Fund, L.P. | Director | S Sale | 2025-10-21 | 2025-10-22 | 25,027 | $28.11 | $703.5K | 1,401,226 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-20 | 2025-10-21 | 11,616 | $30.05 | $349.1K | 1,167,109 | SEC↗ |
| RA Capital Nexus Fund, L.P. | Director | S Sale | 2025-10-20 | 2025-10-22 | 6,553 | $30.12 | $197.4K | 1,426,253 | SEC↗ |
| RA Capital Nexus Fund, L.P. | Director | S Sale | 2025-10-20 | 2025-10-22 | 1,287 | $30.12 | $38.8K | 0 | SEC↗ |
| RA Capital Nexus Fund, L.P. | Director | S Sale | 2025-10-20 | 2025-10-22 | 70,366 | $29.63 | $2.08M | 1,432,806 | SEC↗ |
| RA Capital Nexus Fund, L.P. | Director | S Sale | 2025-10-20 | 2025-10-22 | 13,817 | $29.63 | $409.4K | 1,287 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-17 | 2025-10-17 | 174,594 | $29.12 | $5.08M | 1,546,621 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-17 | 2025-10-17 | 2,492 | $31.00 | $77.3K | 15,104 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-17 | 2025-10-17 | 12,691 | $31.00 | $393.4K | 1,503,172 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-17 | 2025-10-17 | 6,040 | $30.28 | $182.9K | 17,596 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-17 | 2025-10-17 | 30,758 | $30.28 | $931.4K | 1,515,863 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-17 | 2025-10-17 | 34,284 | $29.12 | $998.4K | 23,636 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-17 | 2025-10-21 | 24,689 | $30.22 | $746.1K | 1,179,753 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-17 | 2025-10-21 | 1,028 | $31.00 | $31.9K | 1,178,725 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-16 | 2025-10-17 | 111,041 | $29.32 | $3.26M | 1,737,061 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-16 | 2025-10-17 | 21,804 | $29.32 | $639.3K | 61,032 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-16 | 2025-10-17 | 15,826 | $30.36 | $480.5K | 1,721,235 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-16 | 2025-10-17 | 3,108 | $30.36 | $94.4K | 57,924 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-16 | 2025-10-17 | 20 | $31.35 | $627 | 1,721,215 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-16 | 2025-10-17 | 4 | $31.35 | $125 | 57,920 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-16 | 2025-10-17 | 2,021 | $30.45 | $61.5K | 1,204,442 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-15 | 2025-10-17 | 234 | $31.17 | $7.3K | 1,848,102 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-15 | 2025-10-17 | 46 | $31.17 | $1.4K | 82,836 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-15 | 2025-10-17 | 42,699 | $30.55 | $1.30M | 1,848,336 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | S Sale | 2025-10-15 | 2025-10-17 | 8,384 | $30.55 | $256.1K | 82,882 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-15 | 2025-10-17 | 14,851 | $31.05 | $461.1K | 1,263,267 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-15 | 2025-10-17 | 48,910 | $32.05 | $1.57M | 1,214,357 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-15 | 2025-10-17 | 7,894 | $32.77 | $258.7K | 1,206,463 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-14 | 2025-10-15 | 33,668 | $30.32 | $1.02M | 1,278,118 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-13 | 2025-10-15 | 19,672 | $32.36 | $636.6K | 1,314,120 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-13 | 2025-10-15 | 2,334 | $33.09 | $77.2K | 1,311,786 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-10 | 2025-10-15 | 40,983 | $30.97 | $1.27M | 1,333,792 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-09 | 2025-10-10 | 33,842 | $31.92 | $1.08M | 1,389,817 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-09 | 2025-10-10 | 15,042 | $32.41 | $487.5K | 1,374,775 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-08 | 2025-10-10 | 60,926 | $33.75 | $2.06M | 1,437,995 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-08 | 2025-10-10 | 14,336 | $34.34 | $492.3K | 1,423,659 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-07 | 2025-10-08 | 27,624 | $33.84 | $934.8K | 1,498,921 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-06 | 2025-10-08 | 34,847 | $37.12 | $1.29M | 1,544,701 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-06 | 2025-10-08 | 17,760 | $36.00 | $639.4K | 1,579,548 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-06 | 2025-10-08 | 18,156 | $37.77 | $685.8K | 1,526,545 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-03 | 2025-10-03 | 4,701 | $38.14 | $179.3K | 1,597,308 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-03 | 2025-10-03 | 3,200 | $37.37 | $119.6K | 1,602,009 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-02 | 2025-10-03 | 4,937 | $37.21 | $183.7K | 1,632,723 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-02 | 2025-10-03 | 1,513 | $38.38 | $58.1K | 1,631,210 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-02 | 2025-10-03 | 5,300 | $42.32 | $224.3K | 1,605,209 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-02 | 2025-10-03 | 13,001 | $40.13 | $521.7K | 1,610,509 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-02 | 2025-10-03 | 7,700 | $39.57 | $304.7K | 1,623,510 | SEC↗ |
| Reprogrammed Interchange LLC | 10% Owner | S Sale | 2025-10-01 | 2025-10-03 | 1,400 | $39.19 | $54.9K | 1,637,660 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | A Award deriv | 2025-09-18 | 2025-09-22 | 10,000,000 | $5.00 | $50.00M | 10,000,000 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-09-16 | 2025-09-18 | 447,278 | $1.54 | $688.8K | 32,781,209 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-09-15 | 2025-09-15 | 400,000 | $1.64 | $656.0K | 33,228,487 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-09-12 | 2025-09-15 | 300,000 | $1.75 | $525.0K | 33,628,487 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-09-11 | 2025-09-15 | 284,805 | $1.83 | $521.2K | 33,928,487 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-09-10 | 2025-09-10 | 350,000 | $1.82 | $637.0K | 34,213,292 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-09-09 | 2025-09-10 | 449,226 | $2.00 | $898.5K | 34,563,292 | SEC↗ |
| Reed Sarah Burgess | Director | A Award deriv | 2025-09-08 | 2025-09-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2025-09-08 | 2025-09-10 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-09-08 | 2025-09-10 | 464,421 | $1.99 | $924.2K | 35,012,518 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-09-05 | 2025-09-05 | 400,000 | $1.97 | $788.0K | 35,476,939 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-09-04 | 2025-09-05 | 453,016 | $1.93 | $874.3K | 35,876,939 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-09-03 | 2025-09-05 | 554,612 | $2.00 | $1.11M | 36,329,955 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-08-28 | 2025-08-29 | 806,351 | $2.01 | $1.62M | 36,884,567 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-08-27 | 2025-08-29 | 611,647 | $2.01 | $1.23M | 37,690,918 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-08-26 | 2025-08-27 | 284,190 | $2.08 | $591.1K | 38,302,565 | SEC↗ |
| Hoffman Reid | 10% Owner | S Sale | 2025-08-25 | 2025-08-27 | 387,346 | $2.12 | $821.2K | 38,586,755 | SEC↗ |
| Zuraw Qing Che | Chief Development Officer | A Award deriv | 2025-07-17 | 2025-07-30 | 4,373,040 | — | $0 | 4,373,040 | SEC↗ |
| Zuraw Qing Che | Chief Development Officer | A Award | 2025-07-17 | 2025-07-30 | 937,080 | — | $0 | 937,080 | SEC↗ |
| Cumbo Alexander | Director | A Award deriv | 2025-07-16 | 2025-07-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Detheux Michel | Director | A Award deriv | 2025-07-16 | 2025-07-18 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Mahatme Sandesh | CFO | A Award | 2025-07-09 | 2025-07-10 | 13,882,750 | — | $0 | 13,882,750 | SEC↗ |
| Kress Jean-Paul | CEO and Chairman | A Award deriv | 2025-06-26 | 2025-06-27 | 83,296,638 | — | $0 | 83,296,638 | SEC↗ |
| Namouni Fouad | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Patterson Matthew R | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lundberg Sven Ante | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kalir Erez | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2025-05-22 | 2025-05-23 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Chakraborty Tirtha | Chief Sci Off & Head Tech Op | F Tax w/h | 2025-05-06 | 2025-05-07 | 876 | $0.56 | $491 | 217,416 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2025-05-06 | 2025-05-07 | 2,361 | $0.56 | $1.3K | 911,318 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2025-05-01 | 2025-05-02 | 2,522 | $0.66 | $1.7K | 913,679 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2025-05-01 | 2025-05-02 | 2,751 | $0.66 | $1.8K | 916,201 | SEC↗ |
| Chakraborty Tirtha | Chief Sci Off & Head Tech Op | F Tax w/h | 2025-05-01 | 2025-05-02 | 962 | $0.66 | $635 | 218,292 | SEC↗ |
| Chakraborty Tirtha | Chief Sci Off & Head Tech Op | F Tax w/h | 2025-05-01 | 2025-05-02 | 985 | $0.66 | $650 | 219,254 | SEC↗ |
| Choi Han Wook | Chief Financial Officer | F Tax w/h | 2025-05-01 | 2025-05-02 | 2,061 | $0.66 | $1.4K | 51,280 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | S Sale | 2025-02-13 | 2025-02-18 | 2,227 | $1.42 | $3.2K | 126,625 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | S Sale | 2025-02-10 | 2025-02-12 | 2,554 | $1.37 | $3.5K | 128,852 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | F Tax w/h | 2025-02-06 | 2025-02-07 | 1,180 | $1.50 | $1.8K | 131,406 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2025-02-06 | 2025-02-07 | 2,787 | $1.50 | $4.2K | 918,952 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2025-02-06 | 2025-02-07 | 1,033 | $1.50 | $1.5K | 220,239 | SEC↗ |
| Choi Han Wook | Chief Financial Officer | A Award deriv | 2025-02-03 | 2025-02-05 | 315,000 | — | $0 | 315,000 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 109,000 | — | $0 | 0 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 125,000 | — | $0 | 0 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 315,000 | — | $0 | 315,000 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 364,000 | — | $0 | 364,000 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 364,000 | — | $0 | 0 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 109,000 | — | $0 | 109,000 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 28,800 | — | $0 | 28,800 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 28,800 | — | $0 | 0 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 24,410 | — | $0 | 0 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 24,410 | — | $0 | 24,410 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 70,656 | — | $0 | 0 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 70,656 | — | $0 | 70,656 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 121,323 | — | $0 | 0 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 121,323 | — | $0 | 121,323 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 101,000 | — | $0 | 0 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 101,000 | — | $0 | 101,000 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 76,000 | — | $0 | 0 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 76,000 | — | $0 | 76,000 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 95,500 | — | $0 | 0 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 95,500 | — | $0 | 95,500 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | D To issuer deriv | 2025-02-03 | 2025-02-05 | 107,500 | — | $0 | 0 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 107,500 | — | $0 | 107,500 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2025-02-03 | 2025-02-05 | 315,000 | — | $0 | 315,000 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | D To issuer deriv | 2025-02-03 | 2025-02-05 | 652,086 | — | $0 | 0 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award deriv | 2025-02-03 | 2025-02-05 | 652,086 | — | $0 | 652,086 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award deriv | 2025-02-03 | 2025-02-05 | 470,000 | — | $0 | 470,000 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | D To issuer deriv | 2025-02-03 | 2025-02-05 | 470,000 | — | $0 | 0 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award deriv | 2025-02-03 | 2025-02-05 | 257,500 | — | $0 | 257,500 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | D To issuer deriv | 2025-02-03 | 2025-02-05 | 257,500 | — | $0 | 0 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award deriv | 2025-02-03 | 2025-02-05 | 172,500 | — | $0 | 172,500 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | D To issuer deriv | 2025-02-03 | 2025-02-05 | 172,500 | — | $0 | 0 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award deriv | 2025-02-03 | 2025-02-05 | 376,000 | — | $0 | 376,000 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | D To issuer deriv | 2025-02-03 | 2025-02-05 | 376,000 | — | $0 | 0 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award deriv | 2025-02-03 | 2025-02-05 | 51,060 | — | $0 | 51,060 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | D To issuer deriv | 2025-02-03 | 2025-02-05 | 51,060 | — | $0 | 0 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award deriv | 2025-02-03 | 2025-02-05 | 825,000 | — | $0 | 825,000 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | D To issuer deriv | 2025-02-03 | 2025-02-05 | 147,294 | — | $0 | 0 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award deriv | 2025-02-03 | 2025-02-05 | 147,294 | — | $0 | 147,294 | SEC↗ |
| Choi Han Wook | Chief Financial Officer | A Award | 2025-02-03 | 2025-02-05 | 52,500 | — | $0 | 52,500 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | F Tax w/h | 2025-02-03 | 2025-02-05 | 1,353 | $1.34 | $1.8K | 80,086 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | A Award | 2025-02-03 | 2025-02-05 | 52,500 | — | $0 | 132,586 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award | 2025-02-03 | 2025-02-05 | 52,500 | — | $0 | 221,272 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2025-02-03 | 2025-02-05 | 1,163 | $1.34 | $1.6K | 168,772 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2025-02-03 | 2025-02-05 | 3,248 | $1.34 | $4.4K | 784,239 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award | 2025-02-03 | 2025-02-05 | 137,500 | — | $0 | 921,739 | SEC↗ |
| Kalir Erez | Director | A Award deriv | 2025-01-06 | 2025-01-08 | 60,000 | — | $0 | 60,000 | SEC↗ |
| Hoffman Reid | 10% Owner | P Buy deriv | 2024-12-30 | 2025-01-02 | 48,717,626 | — | $0 | 48,717,626 | SEC↗ |
| Hoffman Reid | 10% Owner | P Buy | 2024-12-30 | 2025-01-02 | 38,974,101 | — | $0 | 38,974,101 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2024-12-30 | 2024-12-30 | 21,121,449 | — | $0 | 21,121,449 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award | 2024-12-30 | 2024-12-30 | 16,897,159 | — | $0 | 37,820,713 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | S Sale | 2024-12-27 | 2024-12-31 | 10,334 | $1.25 | $12.9K | 81,439 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2024-11-06 | 2024-11-08 | 2,361 | $0.86 | $2.0K | 787,487 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | F Tax w/h | 2024-11-06 | 2024-11-08 | 999 | $0.86 | $859 | 91,773 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2024-11-06 | 2024-11-08 | 875 | $0.86 | $753 | 169,935 | SEC↗ |
| Quinlan Amy | Vice President of Finance | F Tax w/h | 2024-11-06 | 2024-11-08 | 206 | $0.86 | $177 | 50,312 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2024-11-01 | 2024-11-05 | 2,751 | $0.80 | $2.2K | 789,848 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | F Tax w/h | 2024-11-01 | 2024-11-05 | 1,146 | $0.80 | $917 | 92,772 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2024-11-01 | 2024-11-05 | 986 | $0.80 | $789 | 170,810 | SEC↗ |
| Quinlan Amy | Vice President of Finance | F Tax w/h | 2024-11-01 | 2024-11-05 | 343 | $0.80 | $274 | 50,518 | SEC↗ |
| Choi Han Wook | Chief Financial Officer | A Award deriv | 2024-09-30 | 2024-10-02 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Quinlan Amy | Vice President of Finance | F Tax w/h | 2024-09-03 | 2024-09-04 | 4,402 | $0.83 | $3.7K | 50,861 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2024-09-03 | 2024-09-04 | 12,657 | $0.83 | $10.5K | 792,599 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2024-09-03 | 2024-09-04 | 5,576 | $0.83 | $4.6K | 171,796 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2024-08-06 | 2024-08-08 | 876 | $0.87 | $762 | 177,372 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2024-08-06 | 2024-08-08 | 2,361 | $0.87 | $2.1K | 805,256 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | F Tax w/h | 2024-08-06 | 2024-08-08 | 999 | $0.87 | $869 | 93,918 | SEC↗ |
| Quinlan Amy | Vice President of Finance | F Tax w/h | 2024-08-06 | 2024-09-04 | 206 | $0.87 | $179 | 55,263 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2024-08-01 | 2024-08-05 | 985 | $0.94 | $926 | 178,248 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | F Tax w/h | 2024-08-01 | 2024-08-05 | 1,146 | $0.94 | $1.1K | 94,917 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2024-08-01 | 2024-08-05 | 2,751 | $0.94 | $2.6K | 807,617 | SEC↗ |
| Quinlan Amy | Vice President of Finance | F Tax w/h | 2024-08-01 | 2024-09-04 | 343 | $0.94 | $322 | 55,469 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | S Sale | 2024-06-03 | 2024-06-04 | 14,645 | $1.39 | $20.4K | 96,063 | SEC↗ |
| Kolchinsky Peter | Director, 10% Owner | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Patterson Matthew R | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lundberg Sven Ante | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Namouni Fouad | Director | A Award deriv | 2024-05-23 | 2024-05-28 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2024-05-06 | 2024-05-07 | 2,361 | $1.75 | $4.1K | 810,368 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2024-05-06 | 2024-05-07 | 875 | $1.75 | $1.5K | 179,233 | SEC↗ |
| Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-05-06 | 2024-05-07 | 834 | $1.75 | $1.5K | 189,403 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | F Tax w/h | 2024-05-06 | 2024-05-07 | 999 | $1.75 | $1.7K | 110,708 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2024-05-01 | 2024-05-03 | 2,751 | $1.77 | $4.9K | 812,729 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2024-05-01 | 2024-05-03 | 985 | $1.77 | $1.7K | 180,108 | SEC↗ |
| Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-05-01 | 2024-05-03 | 917 | $1.77 | $1.6K | 190,237 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | F Tax w/h | 2024-05-01 | 2024-05-03 | 1,146 | $1.77 | $2.0K | 111,707 | SEC↗ |
| Namouni Fouad | Director | A Award deriv | 2024-04-30 | 2024-05-02 | 60,000 | — | $0 | 60,000 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2024-03-01 | 2024-03-05 | 12,657 | $2.27 | $28.7K | 815,480 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2024-03-01 | 2024-03-05 | 5,576 | $2.27 | $12.7K | 181,093 | SEC↗ |
| Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-03-01 | 2024-03-05 | 6,310 | $2.27 | $14.3K | 191,154 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | F Tax w/h | 2024-02-06 | 2024-02-08 | 1,033 | $2.32 | $2.4K | 186,669 | SEC↗ |
| Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | F Tax w/h | 2024-02-06 | 2024-02-08 | 985 | $2.32 | $2.3K | 197,464 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | F Tax w/h | 2024-02-06 | 2024-02-08 | 2,788 | $2.32 | $6.5K | 828,137 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | F Tax w/h | 2024-02-06 | 2024-02-08 | 1,180 | $2.32 | $2.7K | 112,853 | SEC↗ |
| Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | A Award deriv | 2024-01-29 | 2024-01-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award deriv | 2024-01-29 | 2024-01-31 | 470,000 | — | $0 | 470,000 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award deriv | 2024-01-29 | 2024-01-31 | 107,500 | — | $0 | 107,500 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | A Award deriv | 2024-01-29 | 2024-01-31 | 125,000 | — | $0 | 125,000 | SEC↗ |
| Jorgensen Nathan D. | CHIEF FINANCIAL OFFICER | A Award | 2024-01-29 | 2024-01-31 | 50,000 | — | $0 | 198,449 | SEC↗ |
| ANG ROBERT | PRESIDENT AND CEO | A Award | 2024-01-29 | 2024-01-31 | 150,000 | — | $0 | 830,925 | SEC↗ |
| Chakraborty Tirtha | CHIEF SCIENTIFIC OFFICER | A Award | 2024-01-29 | 2024-01-31 | 53,750 | — | $0 | 187,702 | SEC↗ |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | A Award | 2024-01-29 | 2024-01-31 | 62,500 | — | $0 | 114,033 | SEC↗ |
| Attar Eyal C. | Chief Medical Officer | F Tax w/h | 2023-11-06 | 2023-11-08 | 999 | $1.82 | $1.8K | 51,533 | SEC↗ |
| Jorgensen Nathan D. | Chief Financial Officer | F Tax w/h | 2023-11-06 | 2023-11-08 | 834 | $1.82 | $1.5K | 145,647 | SEC↗ |
| ANG ROBERT | President and CEO | F Tax w/h | 2023-11-06 | 2023-11-08 | 2,361 | $1.82 | $4.3K | 680,925 | SEC↗ |
| Chakraborty Tirtha | Chief Scientific Officer | F Tax w/h | 2023-11-06 | 2023-11-08 | 876 | $1.82 | $1.6K | 133,952 | SEC↗ |
| ANG ROBERT | President and CEO | F Tax w/h | 2023-09-01 | 2023-09-06 | 12,657 | $2.67 | $33.8K | 683,286 | SEC↗ |
| Chakraborty Tirtha | Chief Scientific Officer | F Tax w/h | 2023-09-01 | 2023-09-06 | 5,576 | $2.67 | $14.9K | 134,828 | SEC↗ |
| Jorgensen Nathan D. | Chief Financial Officer | F Tax w/h | 2023-09-01 | 2023-09-06 | 6,310 | $2.67 | $16.8K | 146,481 | SEC↗ |
| ANG ROBERT | President and CEO | F Tax w/h | 2023-08-07 | 2023-08-09 | 2,361 | $2.67 | $6.3K | 695,943 | SEC↗ |
| Attar Eyal C. | Chief Medical Officer | F Tax w/h | 2023-08-07 | 2023-08-09 | 999 | $2.67 | $2.7K | 52,532 | SEC↗ |
| Jorgensen Nathan D. | Chief Financial Officer | F Tax w/h | 2023-08-07 | 2023-08-09 | 834 | $2.67 | $2.2K | 152,791 | SEC↗ |
| Chakraborty Tirtha | Chief Scientific Officer | F Tax w/h | 2023-08-07 | 2023-08-09 | 875 | $2.67 | $2.3K | 140,404 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2023-05-26 | 2023-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lundberg Sven Ante | Director | A Award deriv | 2023-05-26 | 2023-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2023-05-26 | 2023-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Patterson Matthew R | Director | A Award deriv | 2023-05-26 | 2023-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2023-05-26 | 2023-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | A Award deriv | 2023-05-26 | 2023-06-02 | 30,000 | — | $0 | 30,000 | SEC↗ |
| Attar Eyal C. | Chief Medical Officer | F Tax w/h | 2023-05-08 | 2023-05-10 | 969 | $4.14 | $4.0K | 53,531 | SEC↗ |
| Jorgensen Nathan D. | Chief Financial Officer | F Tax w/h | 2023-05-08 | 2023-05-10 | 834 | $4.14 | $3.5K | 153,625 | SEC↗ |
| Chakraborty Tirtha | Chief Scientific Officer | F Tax w/h | 2023-05-08 | 2023-05-10 | 875 | $4.14 | $3.6K | 141,279 | SEC↗ |
| ANG ROBERT | President and CEO | F Tax w/h | 2023-05-08 | 2023-05-10 | 2,361 | $4.14 | $9.8K | 698,304 | SEC↗ |
| Jorgensen Nathan D. | Chief Financial Officer | F Tax w/h | 2023-03-01 | 2023-03-02 | 6,310 | $5.51 | $34.8K | 154,459 | SEC↗ |
| Chakraborty Tirtha | Chief Scientific Officer | F Tax w/h | 2023-03-01 | 2023-03-02 | 5,576 | $5.51 | $30.7K | 142,154 | SEC↗ |
| ANG ROBERT | President and CEO | F Tax w/h | 2023-03-01 | 2023-03-02 | 12,657 | $5.51 | $69.7K | 700,665 | SEC↗ |
| Chakraborty Tirtha | Chief Scientific Officer | A Award deriv | 2023-02-06 | 2023-02-08 | 95,500 | — | $0 | 95,500 | SEC↗ |
| Jorgensen Nathan D. | Chief Financial Officer | A Award deriv | 2023-02-06 | 2023-02-08 | 91,000 | — | $0 | 91,000 | SEC↗ |
| Attar Eyal C. | Chief Medical Officer | A Award deriv | 2023-02-06 | 2023-02-08 | 109,000 | — | $0 | 109,000 | SEC↗ |
| ANG ROBERT | President and CEO | A Award deriv | 2023-02-06 | 2023-02-08 | 257,500 | — | $0 | 257,500 | SEC↗ |
| Chakraborty Tirtha | Chief Scientific Officer | A Award | 2023-02-06 | 2023-02-08 | 47,750 | — | $0 | 147,730 | SEC↗ |
| Jorgensen Nathan D. | Chief Financial Officer | A Award | 2023-02-06 | 2023-02-08 | 45,500 | — | $0 | 160,769 | SEC↗ |
| Attar Eyal C. | Chief Medical Officer | A Award | 2023-02-06 | 2023-02-08 | 54,500 | — | $0 | 54,500 | SEC↗ |
| ANG ROBERT | President and CEO | A Award | 2023-02-06 | 2023-02-08 | 128,750 | — | $0 | 713,322 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | A Award | 2022-12-09 | 2022-12-09 | 11,627,907 | $4.30 | $50.00M | 20,923,554 | SEC↗ |
| Attar Eyal C. | Chief Medical Officer | A Award deriv | 2022-10-11 | 2022-10-12 | 364,000 | — | $0 | 364,000 | SEC↗ |
| ANG ROBERT | President and CEO | A Award deriv | 2022-09-13 | 2022-09-15 | 172,500 | — | $0 | 172,500 | SEC↗ |
| ANG ROBERT | President and CEO | A Award | 2022-09-13 | 2022-09-15 | 172,500 | — | $0 | 584,572 | SEC↗ |
| Jorgensen Nathan D. | Chief Financial Officer | A Award deriv | 2022-09-01 | 2022-09-06 | 86,000 | — | $0 | 86,000 | SEC↗ |
| Chakraborty Tirtha | Chief Scientific Officer | A Award deriv | 2022-09-01 | 2022-09-06 | 76,000 | — | $0 | 76,000 | SEC↗ |
| Jorgensen Nathan D. | Chief Financial Officer | A Award | 2022-09-01 | 2022-09-06 | 86,000 | — | $0 | 115,269 | SEC↗ |
| Chakraborty Tirtha | Chief Scientific Officer | A Award | 2022-09-01 | 2022-09-06 | 76,000 | — | $0 | 96,980 | SEC↗ |
| Beckman Daniella | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 16,911 | — | $0 | 16,911 | SEC↗ |
| Lubner David Charles | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 16,911 | — | $0 | 16,911 | SEC↗ |
| Lundberg Sven Ante | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 16,911 | — | $0 | 16,911 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | A Award deriv | 2022-06-14 | 2022-06-16 | 16,911 | — | $0 | 16,911 | SEC↗ |
| Patterson Matthew R | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 16,911 | — | $0 | 16,911 | SEC↗ |
| Resnick Joshua | Director | A Award deriv | 2022-06-14 | 2022-06-16 | 16,911 | — | $0 | 16,911 | SEC↗ |
| Shah Rajeev M. | Director, 10% Owner | A Award deriv | 2022-06-14 | 2022-06-17 | 16,911 | — | $0 | 16,911 | SEC↗ |
| ANG ROBERT | President and CEO | A Award deriv | 2022-02-01 | 2022-02-03 | 376,000 | — | $0 | 376,000 | SEC↗ |
| Chakraborty Tirtha | Chief Scientific Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 101,000 | — | $0 | 101,000 | SEC↗ |
| Jorgensen Nathan D. | Chief Financial Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 135,000 | — | $0 | 135,000 | SEC↗ |
| Slapak Christopher | Chief Medical Officer | A Award deriv | 2022-02-01 | 2022-02-03 | 116,000 | — | $0 | 116,000 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2021-11-16 | 2021-11-18 | 91,836 | $15.30 | $1.41M | 1,766,634 | SEC↗ |
| PARMAR KUSH | Director, 10% Owner | S Sale | 2021-11-16 | 2021-11-18 | 238,870 | $15.30 | $3.65M | 4,595,089 | SEC↗ |